✦ LIBER ✦

Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients

✍ Scribed by Andre N. Gay; Shirong Chang; Lindsey Rutland; Ling Yu; Sarah Byeseda; Bindi Naik-Mathuria; Darrell L. Cass; Heidi Russell; Oluyinka O. Olutoye

Book ID: 116686970
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 334 KB
Volume: 43
Category: Article
ISSN: 0022-3468
DOI: 10.1016/j.jpedsurg.2007.12.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effects of Age, Disease State, and G

The Effects of Age, Disease State, and Granulocyte Colony-Stimulating Factor on Progenitor Cell Count and Function in Patients Undergoing Cell Therapy for Cardiac Disease

✍ Mozid, Abdul M.; Jones, Dan; Arnous, Samer; Saunders, Natalie; Wragg, Andrew; Ma 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 739 KB

Granulocyte colony-stimulating factor sh

Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia

✍ W. Kern; C. Aul; G. Maschmeyer; R. Kuse; A. Kerkhoff; A. Grote-Metke; H. Eimerma 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 203 KB

High-Dose Etoposide Plus Granulocyte Col

High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma

✍ Hyun, Shin Young; Cheong, June-Won; Kim, Soo-Jeong; Min, Yoo Hong; Yang, Deok-Hw 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 260 KB

P-849 The economic implications of addin

P-849 The economic implications of adding granulocyte-colony stimulating factor (G-CSF) andlor antibiotics as secondary prophylaxis to small cell lung cancer (SCLC) patients at risk of febrile neutropenia (FN): A Markov model based on the clinical results of a prospective randomised phase III study

✍ Timmer-Bonte, J.; Termeer, E.; Adang, E.; Tjan-Heijnen, V. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Low-dose cytosine arabinoside (LD-AraC)

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group

✍ Zwierzina, H; Suciu, S; Loeffler-Ragg, J; Neuwirtova, R; Fenaux, P; Beksac, M; H 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB